These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19852983)

  • 1. In search of a selective therapy of viral infections.
    De Clercq E
    Antiviral Res; 2010 Jan; 85(1):19-24. PubMed ID: 19852983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 40-year journey in search of selective antiviral chemotherapy.
    De Clercq E
    Annu Rev Pharmacol Toxicol; 2011; 51():1-24. PubMed ID: 20809796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine.
    Cihlar T; Ray AS
    Antiviral Res; 2010 Jan; 85(1):39-58. PubMed ID: 19887088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).
    de Béthune MP
    Antiviral Res; 2010 Jan; 85(1):75-90. PubMed ID: 19781578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drug discovery and development: where chemistry meets with biomedicine.
    De Clercq E
    Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy.
    McColl DJ; Chen X
    Antiviral Res; 2010 Jan; 85(1):101-18. PubMed ID: 19925830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of human immunodeficiency virus drug resistance: an update.
    Menéndez-Arias L
    Antiviral Res; 2010 Jan; 85(1):210-31. PubMed ID: 19616029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E; Holý A
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current acquisitions in antiviral drugs (anti-HIV)].
    De Clercq E; Snoeck R
    J Pharm Belg; 1992; 47(4):317-22. PubMed ID: 1383488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of HIV-1 resistance.
    Paredes R; Clotet B
    Antiviral Res; 2010 Jan; 85(1):245-65. PubMed ID: 19808056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of HIV treatment guidelines: current state-of-the-art of ART.
    Zolopa AR
    Antiviral Res; 2010 Jan; 85(1):241-4. PubMed ID: 19883695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Running a tightrope: regulatory challenges in the development of antiretrovirals.
    Naeger LK; Struble KA; Murray JS; Birnkrant DB
    Antiviral Res; 2010 Jan; 85(1):232-40. PubMed ID: 19665489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: a brief history of stavudine (D4T) and its comparison with other dideoxynucleosides.
    Martin JC; Hitchcock MJ; De Clercq E; Prusoff WH
    Antiviral Res; 2010 Jan; 85(1):34-8. PubMed ID: 19854224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective virus inhibitors.
    De Clercq E
    Microbiologica; 1990 Apr; 13(2):165-78. PubMed ID: 1693749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antiretrovirals in animal models of HIV infection.
    Van Rompay KK
    Antiviral Res; 2010 Jan; 85(1):159-75. PubMed ID: 19622373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective.
    De Clercq E
    Adv Virus Res; 2009; 73():1-53. PubMed ID: 19695380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.